Pyrido [2,1-a] isoquinoline derivatives
US7718666B2 · kind B2 · utility
61Cited by
9References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 2004 |
| Grant date | May 18, 2010 |
| Priority date | — |
| Expiry date | Jun 17, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I)wherein R1 is as defined in the description, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP-IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.